Rapport Therapeutics Newsroom

Jefferies Maintains Rapport Therapeutics(RAPP.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsDec 9 08:32 ET

Rapport Therapeutics, Inc. (RAPP) Receives a Buy From Jefferies

TipRanksDec 9 08:28 ET

TD Cowen Maintains Rapport Therapeutics(RAPP.US) With Buy Rating

Moomoo NewsNov 7 12:31 ET

Rapport Therapeutics, Inc. (RAPP) Gets a Buy From TD Cowen

TipRanksNov 7 12:05 ET

Rapport Therapeutics Analyst Ratings

BenzingaOct 18 09:01 ET

Rapport Therapeutics Initiated With a Buy at JonesResearch

TipRanksOct 17 18:30 ET

JonesTrading Initiates Rapport Therapeutics(RAPP.US) With Buy Rating, Announces Target Price $42

Moomoo NewsOct 17 17:32 ET

Jefferies Maintains Rapport Therapeutics(RAPP.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsOct 3 08:31 ET

Buy Rating Affirmed for Rapport Therapeutics Amid Promising Phase IIa Epilepsy Study and RAP-219's Market Potential

TipRanksOct 3 08:19 ET

TD Cowen Sticks to Their Buy Rating for Rapport Therapeutics, Inc. (RAPP)

TipRanksAug 8 14:28 ET

Rapport Therapeutics Analyst Ratings

BenzingaJul 2 05:55 ET

Buy Rating for Rapport Therapeutics: Disruptive CNS Treatments and Promising Drug Efficacy

TipRanksJul 2 05:02 ET